It's even possible that we could soon see the beginning of a new bull market. Investors could have the equivalent of this happen with the stock market. If the stock market indeed retreats, one of the most likely culprits is that investors fear a recession is coming.
After growth stocks were Wall Street's savior in 2021, they were primarily responsible for dragging the major indexes into a bear market last year. The growth-dependent Nasdaq Composite and Nasdaq 100 -- an index comprised of the 100 largest nonfinancial companies listed on the Nasdaq exchange -- each plunged 33% in 2022. Thankfully, when there's pain on Wall Street, you can always find opportunity.
Let us take a look at what is in store for some of the biotech stocks VRTX, INCY and EXEL, which are scheduled to report on Feb 7.